Meeting Coverage
ECTRIMS
European Committee for Treatment and Research in Multiple Sclerosis
Latest ECTRIMS Meeting Coverage
Subgroup analysis shows brain penetration
NfL changes occurred in advance of, not coincident with, clinical worsening
MS field faces immense opportunity to move beyond disease suppression, keynote speaker says
Both provided rapid B-cell depletion
CD40 ligand inhibitor leads to sustained reduction of MRI disease activity
DELIVER-MS shows racial and ethnic diversity in clinical trials can be improved
Rituximab did not show non-inferiority in comparative effectiveness study
ARISE trial investigates radiologically isolated syndrome
Disability, relapses no better than disease-modifying drug
Major congenital anomalies, other adverse outcomes were rare
"If you rely on having a clinical relapse, you may wait a long time"
How this relates to infection outcomes or risk of infecting others is unknown
Analysis suggests smoking cessation has benefits in MS
Evobrutinib shows effect on marker of chronic inflammation